Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Novavax, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference, highlighting its ongoing commitment to addressing global health challenges through innovative vaccine technology [1]. Group 1: Conference Details - The presentation is scheduled for Wednesday, January 14, 2026, at 4:30 p.m. Pacific Time [2]. - The event will take place in San Francisco, CA, and a webcast will be available on the company's website, with a replay accessible for 30 days [2]. Group 2: Company Overview - Novavax focuses on tackling significant health challenges using its expertise in vaccines and a proven technology platform, which includes protein-based nanoparticles and the Matrix-M adjuvant [2]. - The company's growth strategy aims to optimize existing partnerships, expand access to its technology through research and development, and pursue new collaborations in infectious disease and beyond [2].